China’s fitness-is-best message has largely been the handiwork of Coca-Cola and other Western food and beverage giants, according to a pair of new studies that document how those companies have helped shape decades of Chinese science and public policy on obesity and illnesses like Type 2 diabetes and hypertension

Quick Read

Inside the controversial world of epigenetics research

Quick Read

The results highlight the potential for company payments to influence doctors’ treatment decisions, said Dr. Yoram Unguru of the Johns Hopkins Berman Institute of Bioethics in Baltimore, who wasn’t involved in the study. “Patients trust that their physicians will make objective and evidence-based decisions on their behalf, which reflect their interests and that these decisions will also limit harms,”

Quick Read

KHN launches “Pre$cription for Power,” a groundbreaking database to expose Big Pharma’s ties to patient groups

Quick Read

When teaching hospitals put pharmaceutical sales representatives on a shorter leash, their doctors tended to order fewer promoted brand-name drugs and used more generic versions instead, a study published Tuesday in JAMA, the journal of the American Medical Association, shows

Quick Read

They are a little-known presence in many operating rooms, offering technical expertise to surgeons installing new knees, implanting cardiac defibrillators or performing delicate spine surgery

Quick Read

Physicians whose state boards have sanctioned them for harming patients, unnecessarily prescribing addictive drugs, bilking federal insurance programs and even sexual misconduct nonetheless continue to receive payments for consulting, giving talks about products, and more

Quick Read

A ProPublica analysis shows that where a hospital is located and who owns it make a big difference in what share of its doctors take industry payments

Quick Read